Header Logo

Connection

Groesbeck Parham to Female

Back to Details
This is a "connection" page, showing publications Groesbeck Parham has written about Female.
Groesbeck Parham
Connection Strength
4.240
Female
  1. A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trial. Nat Med. 2024 Sep; 30(9):2596-2604.
    View in: PubMed
    Score: 0.131
  2. Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia. Cancer Med. 2024 Jun; 13(11):e7355.
    View in: PubMed
    Score: 0.131
  3. Three-year survival of breast cancer patients attending a one-stop breast care clinic nested within a primary care health facility in sub-Saharan Africa-Zambia. Int J Cancer. 2024 Jul 15; 155(2):261-269.
    View in: PubMed
    Score: 0.129
  4. Racial disparities in endometrial cancer: Where are we after 26?years? Gynecol Oncol. 2024 05; 184:236-242.
    View in: PubMed
    Score: 0.128
  5. The impact of Black founding fathers on the specialty of gynecologic oncology. Gynecol Oncol. 2024 06; 185:42-45.
    View in: PubMed
    Score: 0.128
  6. User Experience With Low-Cost Virtual Reality Cancer Surgery Simulation in an African Setting. JCO Glob Oncol. 2021 03; 7:435-442.
    View in: PubMed
    Score: 0.104
  7. The Ability to Look: Management of Breast Disease in the Democratic Republic of the Congo Using Smart Ultrasound Technology. J Am Coll Surg. 2021 04; 232(4):636-640.
    View in: PubMed
    Score: 0.103
  8. Minimizing Delays in the Breast Cancer Pathway by Integrating Breast Specialty Care Services at the Primary Health Care Level in Zambia. JCO Glob Oncol. 2020 06; 6:859-865.
    View in: PubMed
    Score: 0.099
  9. Partnering with traditional Chiefs to expand access to cervical cancer prevention services in rural Zambia. Int J Gynaecol Obstet. 2019 Mar; 144(3):297-301.
    View in: PubMed
    Score: 0.090
  10. Demonstration of an algorithm to overcome health system-related barriers to timely diagnosis of breast diseases in rural Zambia. PLoS One. 2018; 13(5):e0196985.
    View in: PubMed
    Score: 0.086
  11. Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early Outcomes. J Glob Oncol. 2018 09; 4:1-8.
    View in: PubMed
    Score: 0.082
  12. Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia. J Low Genit Tract Dis. 2016 Jul; 20(3):218-23.
    View in: PubMed
    Score: 0.076
  13. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia. J Acquir Immune Defic Syndr. 2015 Sep 01; 70(1):e20-6.
    View in: PubMed
    Score: 0.071
  14. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One. 2015; 10(4):e0122169.
    View in: PubMed
    Score: 0.069
  15. Minimizing verification bias in cervical cancer screening of HIV-infected women. Int J Gynaecol Obstet. 2015 Mar; 128(3):269-70.
    View in: PubMed
    Score: 0.067
  16. Monitoring the performance of "screen-and-treat" cervical cancer prevention programs. Int J Gynaecol Obstet. 2014 Jul; 126(1):88-89.
    View in: PubMed
    Score: 0.064
  17. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013 Dec 29; 31 Suppl 5:F32-46.
    View in: PubMed
    Score: 0.064
  18. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. PLoS One. 2013; 8(9):e74607.
    View in: PubMed
    Score: 0.062
  19. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med. 2011 May; 8(5):e1001032.
    View in: PubMed
    Score: 0.053
  20. eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. J Low Genit Tract Dis. 2010 Jul; 14(3):167-73.
    View in: PubMed
    Score: 0.050
  21. Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators. Glob Health Promot. 2010 Jun; 17(2 Suppl):47-50.
    View in: PubMed
    Score: 0.050
  22. HPV screening for cervical cancer in rural India. N Engl J Med. 2009 Jul 16; 361(3):305; author reply 306.
    View in: PubMed
    Score: 0.047
  23. Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS. 2009 Mar 27; 23(6):N1-5.
    View in: PubMed
    Score: 0.046
  24. Integrating cervical cancer prevention in HIV/AIDS treatment and care programmes. Bull World Health Organ. 2008 Aug; 86(8):D-E.
    View in: PubMed
    Score: 0.044
  25. Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Gynecol Oncol. 2008 Sep; 110(3):402-7.
    View in: PubMed
    Score: 0.043
  26. The disparity of cervical cancer in diverse populations. Gynecol Oncol. 2008 May; 109(2 Suppl):S22-30.
    View in: PubMed
    Score: 0.043
  27. Strategies for achieving healthy energy balance among African Americans in the Mississippi Delta. Prev Chronic Dis. 2007 Oct; 4(4):A97.
    View in: PubMed
    Score: 0.041
  28. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer. 2007 May 07; 96(9):1480-3.
    View in: PubMed
    Score: 0.040
  29. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol. 2006 Dec; 103(3):1017-22.
    View in: PubMed
    Score: 0.038
  30. Addressing disparities through coalition building: Alabama REACH 2010 lessons learned. J Health Care Poor Underserved. 2006 May; 17(2 Suppl):55-77.
    View in: PubMed
    Score: 0.037
  31. Disparities in cervical cancer screening, treatment and outcomes. Ethn Dis. 2006; 16(2 Suppl 3):S3-63-6.
    View in: PubMed
    Score: 0.036
  32. Survival deficits in young women with breast cancer in sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort. J Natl Cancer Inst. 2025 Nov 01; 117(11):2298-2307.
    View in: PubMed
    Score: 0.036
  33. Breast cancer overall survival, annual risks of death, and survival gap apportionment in sub-Saharan Africa (ABC-DO): 7-year follow-up of a prospective cohort study. Lancet Glob Health. 2025 Oct; 13(10):e1681-e1690.
    View in: PubMed
    Score: 0.036
  34. Racial disparities affecting the reproductive health of African-American women. Med Clin North Am. 2005 Sep; 89(5):935-43, 941.
    View in: PubMed
    Score: 0.036
  35. Predictors of outcomes for women with cervical carcinoma. Gynecol Oncol. 2005 Nov; 99(2):432-6.
    View in: PubMed
    Score: 0.036
  36. Economic evaluation of thermal ablation compared to cryotherapy and loop diathermy in a screen-and-treat approach to cervical cancer, Zambia. Bull World Health Organ. 2025 Sep 01; 103(9):530-540.
    View in: PubMed
    Score: 0.035
  37. Vaginal microbiome composition in women with HIV undergoing treatment of cervical transformation zone in a screen and treat program in Zambia. AIDS. 2025 Jul 15; 39(9):1303-1306.
    View in: PubMed
    Score: 0.035
  38. A multidisciplinary approach to strengthening patient navigation among gynaecologic malignancy patients at the Cancer Diseases Hospital in Zambia. J Cancer Policy. 2025 Sep; 45:100608.
    View in: PubMed
    Score: 0.035
  39. Dairy report one-sided: dairy products contribute to cancer risks. J Natl Med Assoc. 2005 Apr; 97(4):582-3.
    View in: PubMed
    Score: 0.035
  40. Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study. Lancet Glob Health. 2024 Jul; 12(7):e1111-e1119.
    View in: PubMed
    Score: 0.033
  41. Improving access to safe, quality surgical care for gynecologic cancers through capacity-building interventions in low- and middle-income countries: A scoping review. Int J Gynaecol Obstet. 2024 May; 165(2):552-561.
    View in: PubMed
    Score: 0.031
  42. Comparison of cell collection and direct visualization cervical cancer screening adjuncts. Am J Obstet Gynecol. 2003 Mar; 188(3 Suppl):S13-20.
    View in: PubMed
    Score: 0.030
  43. Reproductive history and breast cancer survival: Findings from the African breast cancer-Disparities in outcomes cohort and implications of Africa's fertility transition on breast cancer prognosis. Int J Cancer. 2023 05 01; 152(9):1804-1816.
    View in: PubMed
    Score: 0.030
  44. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review. BMC Womens Health. 2022 12 02; 22(1):486.
    View in: PubMed
    Score: 0.029
  45. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10. Int J Radiat Oncol Biol Phys. 2002 Dec 01; 54(5):1345-55.
    View in: PubMed
    Score: 0.029
  46. Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 2022 12; 28(12):2563-2572.
    View in: PubMed
    Score: 0.029
  47. Cancer research across Africa: a comparative bibliometric analysis. BMJ Glob Health. 2022 11; 7(11).
    View in: PubMed
    Score: 0.029
  48. Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer. N Engl J Med. 2002 May 30; 346(22):1752-3.
    View in: PubMed
    Score: 0.028
  49. Treatment guideline concordance, initiation, and abandonment in patients with non-metastatic breast cancer from the African Breast Cancer-Disparities in Outcomes (ABC-DO) cohort in sub-Saharan Africa: a prospective cohort study. Lancet Oncol. 2022 06; 23(6):729-738.
    View in: PubMed
    Score: 0.028
  50. Overexpression of HER-2/neu in uterine serous papillary cancer. Clin Cancer Res. 2002 May; 8(5):1271-9.
    View in: PubMed
    Score: 0.028
  51. Self-reported arm and shoulder problems in breast cancer survivors in Sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort study. Breast Cancer Res. 2021 11 24; 23(1):109.
    View in: PubMed
    Score: 0.027
  52. Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer. BJOG. 2001 Aug; 108(8):804-8.
    View in: PubMed
    Score: 0.027
  53. The use a virtual interactive system to enhance gynecologic oncology multi-disciplinary care in Zambia. J Cancer Policy. 2021 09; 29:100298.
    View in: PubMed
    Score: 0.027
  54. Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer. 2001 Feb 15; 91(4):869-73.
    View in: PubMed
    Score: 0.026
  55. Maternally Orphaned Children and Intergenerational Concerns Associated With Breast Cancer Deaths Among Women in Sub-Saharan Africa. JAMA Oncol. 2021 02 01; 7(2):285-289.
    View in: PubMed
    Score: 0.026
  56. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer. Gynecol Obstet Invest. 2001; 51(4):254-61.
    View in: PubMed
    Score: 0.026
  57. Geospatial barriers to healthcare access for breast cancer diagnosis in sub-Saharan African settings: The African Breast Cancer-Disparities in Outcomes Cohort Study. Int J Cancer. 2021 05 01; 148(9):2212-2226.
    View in: PubMed
    Score: 0.026
  58. Preexisting morbidity profile of women newly diagnosed with breast cancer in sub-Saharan Africa: African Breast Cancer-Disparities in Outcomes study. Int J Cancer. 2021 05 01; 148(9):2158-2170.
    View in: PubMed
    Score: 0.026
  59. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys. 2000 Nov 01; 48(4):997-1006.
    View in: PubMed
    Score: 0.026
  60. Few Losses to Follow-up in a Sub-Saharan African Cancer Cohort via Active Mobile Health Follow-up. Am J Epidemiol. 2020 10 01; 189(10):1185-1196.
    View in: PubMed
    Score: 0.025
  61. Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells. Obstet Gynecol. 2000 Sep; 96(3):422-30.
    View in: PubMed
    Score: 0.025
  62. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Am J Obstet Gynecol. 2000 Sep; 183(3):601-9.
    View in: PubMed
    Score: 0.025
  63. Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study. Lancet Glob Health. 2020 09; 8(9):e1203-e1212.
    View in: PubMed
    Score: 0.025
  64. Dissecting the journey to breast cancer diagnosis in sub-Saharan Africa: Findings from the multicountry ABC-DO cohort study. Int J Cancer. 2021 01 15; 148(2):340-351.
    View in: PubMed
    Score: 0.025
  65. Comparison of immediate and deferred colposcopy in a cervical screening program. Obstet Gynecol. 2000 Mar; 95(3):340-4.
    View in: PubMed
    Score: 0.024
  66. Development, characterization and distribution of adoptively transferred peripheral blood lymphocytes primed by human papillomavirus 18 E7--pulsed autologous dendritic cells in a patient with metastatic adenocarcinoma of the uterine cervix. Eur J Gynaecol Oncol. 2000; 21(1):17-23.
    View in: PubMed
    Score: 0.024
  67. Development and therapeutic effect of adoptively transferred T cells primed by tumor lysate-pulsed autologous dendritic cells in a patient with metastatic endometrial cancer. Gynecol Obstet Invest. 2000; 49(3):194-203.
    View in: PubMed
    Score: 0.024
  68. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. Lancet Oncol. 2020 01; 21(1):175-184.
    View in: PubMed
    Score: 0.024
  69. Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Obstet Gynecol. 1999 Jul; 94(1):78-82.
    View in: PubMed
    Score: 0.023
  70. Using Low-Cost Virtual Reality Simulation to Build Surgical Capacity for Cervical Cancer Treatment. J Glob Oncol. 2019 05; 5:1-7.
    View in: PubMed
    Score: 0.023
  71. Challenges, Opportunities, and Priorities for Advancing Breast Cancer Control in Zambia: A Consultative Meeting on Breast Cancer Control. J Glob Oncol. 2019 03; 5:1-7.
    View in: PubMed
    Score: 0.023
  72. Secretion of vascular endothelial growth factor in ovarian cancer. Eur J Gynaecol Oncol. 1999; 20(3):177-81.
    View in: PubMed
    Score: 0.022
  73. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma. Cancer. 1998 Dec 01; 83(11):2346-52.
    View in: PubMed
    Score: 0.022
  74. Differences in Cervical Cancer Screening Knowledge and Practices by HIV Status and Geographic Location: Implication for Program Implementation in Zambia. Afr J Reprod Health. 2018 Dec; 22(4):92-101.
    View in: PubMed
    Score: 0.022
  75. Race as a factor in the outcome of patients with cervical cancer: lift the veil to find the wounded spirit. Gynecol Oncol. 1998 Nov; 71(2):149-50.
    View in: PubMed
    Score: 0.022
  76. Retinoic acid up-regulates the expression of major histocompatibility complex molecules and adhesion/costimulation molecules (specifically, intercellular adhesion molecule ICAM-1) in human cervical cancer. Am J Obstet Gynecol. 1998 Oct; 179(4):1020-5.
    View in: PubMed
    Score: 0.022
  77. Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human cervical cancer. Gynecol Oncol. 1998 Aug; 70(2):195-201.
    View in: PubMed
    Score: 0.022
  78. Breast cancer awareness in the sub-Saharan African ABC-DO cohort: African Breast Cancer-Disparities in Outcomes study. Cancer Causes Control. 2018 08; 29(8):721-730.
    View in: PubMed
    Score: 0.022
  79. The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in human cervical cancer. Int J Radiat Biol. 1998 Jun; 73(6):699-704.
    View in: PubMed
    Score: 0.022
  80. Effects of retinoic acid combined with interferon-gamma on the expression of major-histocompatibility-complex molecules and intercellular adhesion molecule-1 in human cervical cancer. Int J Cancer. 1998 Jan 19; 75(2):254-8.
    View in: PubMed
    Score: 0.021
  81. Routine lymph node dissection in the treatment of early stage cancer: are we doing the right thing? Gynecol Oncol. 1998 Jan; 68(1):1-3.
    View in: PubMed
    Score: 0.021
  82. Effects of retinoic acid on the expression of a tumor rejection antigen (heat shock protein gp96) in human cervical cancer. Eur J Gynaecol Oncol. 1998; 19(3):229-33.
    View in: PubMed
    Score: 0.021
  83. Drivers of advanced stage at breast cancer diagnosis in the multicountry African breast cancer - disparities in outcomes (ABC-DO) study. Int J Cancer. 2018 04 15; 142(8):1568-1579.
    View in: PubMed
    Score: 0.021
  84. Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer. Int J Radiat Oncol Biol Phys. 1997 Oct 01; 39(3):737-42.
    View in: PubMed
    Score: 0.021
  85. Effectiveness of the Papanicolaou smear and speculoscopy as compared with the Papanicolaou smear alone: a community-based clinical trial. Obstet Gynecol. 1997 Sep; 90(3):421-7.
    View in: PubMed
    Score: 0.020
  86. The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women. Cancer. 1997 Aug 15; 80(4):816-26.
    View in: PubMed
    Score: 0.020
  87. State of differentiation affects the response of endometrial adenocarcinoma cells to retinoic acid. Anticancer Res. 1997 May-Jun; 17(3C):1973-83.
    View in: PubMed
    Score: 0.020
  88. Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1997 Mar; 64(3):477-80.
    View in: PubMed
    Score: 0.020
  89. Racial differences in surgically staged patients with endometrial cancer. J Natl Med Assoc. 1997 Feb; 89(2):134-40.
    View in: PubMed
    Score: 0.020
  90. The global burden of women's cancers: a grand challenge in global health. Lancet. 2017 02 25; 389(10071):847-860.
    View in: PubMed
    Score: 0.019
  91. African Breast Cancer-Disparities in Outcomes (ABC-DO): protocol of a multicountry mobile health prospective study of breast cancer survival in sub-Saharan Africa. BMJ Open. 2016 08 23; 6(8):e011390.
    View in: PubMed
    Score: 0.019
  92. Point-of-care test for cervical cancer in LMICs. Oncotarget. 2016 Apr 05; 7(14):18787-97.
    View in: PubMed
    Score: 0.019
  93. Gynecologic cancer among the socioeconomically disadvantaged. Cancer. 1995 Nov 15; 76(10 Suppl):2176-80.
    View in: PubMed
    Score: 0.018
  94. The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, Zambia. J Low Genit Tract Dis. 2015 Oct; 19(4):301-6.
    View in: PubMed
    Score: 0.018
  95. Cervical Cancer Screening in Cameroon: Interobserver Agreement on the Interpretation of Digital Cervicography Results. J Low Genit Tract Dis. 2015 Oct; 19(4):288-94.
    View in: PubMed
    Score: 0.018
  96. The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. BMC Cancer. 2015 Jul 24; 15:541.
    View in: PubMed
    Score: 0.018
  97. Primary lymphatic dissemination of malignant elements in a mature cystic ovarian teratoma. Gynecol Oncol. 1995 May; 57(2):250-3.
    View in: PubMed
    Score: 0.017
  98. Preference for human papillomavirus-based cervical cancer screening: results of a choice-based conjoint study in Zambia. J Low Genit Tract Dis. 2015 Apr; 19(2):119-23.
    View in: PubMed
    Score: 0.017
  99. Can you screen for ovarian cancer? J Natl Med Assoc. 1995 Feb; 87(2):109-12.
    View in: PubMed
    Score: 0.017
  100. Identification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional study. Virol J. 2015 Jan 16; 12:2.
    View in: PubMed
    Score: 0.017
  101. Metastasis from a stage IB cervical adenocarcinoma in a transposed ovary: a case report and review of the literature. Gynecol Oncol. 1994 Dec; 55(3 Pt 1):469-72.
    View in: PubMed
    Score: 0.017
  102. Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2014 Oct 01; 67(2):212-5.
    View in: PubMed
    Score: 0.017
  103. Significance of a first-time atypical Papanicolaou smear in a young, high-risk African-American and Latino-American population. J Natl Med Assoc. 1994 Apr; 86(4):273-7.
    View in: PubMed
    Score: 0.016
  104. Recommendations for cervical cancer prevention in sub-saharan Africa. Vaccine. 2013 Dec 29; 31 Suppl 5:F73-4.
    View in: PubMed
    Score: 0.016
  105. Innovative approaches to promoting cervical health and raising cervical cancer awareness by use of existing cultural structures in resource-limited countries: experiences with traditional marriage counseling in Zambia. Glob Health Promot. 2013 Dec; 20(4 Suppl):57-64.
    View in: PubMed
    Score: 0.016
  106. Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease. Reprod Sci. 2012 Nov; 19(11):1154-62.
    View in: PubMed
    Score: 0.014
  107. 'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia. Soc Sci Med. 2012 May; 74(10):1486-93.
    View in: PubMed
    Score: 0.014
  108. Motivations and experiences of women who accessed "see and treat" cervical cancer prevention services in Zambia. J Psychosom Obstet Gynaecol. 2012 Jun; 33(2):91-8.
    View in: PubMed
    Score: 0.014
  109. Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila). 2012 Jan; 5(1):11-7.
    View in: PubMed
    Score: 0.014
  110. Hyperparathyroidism secondary to parathyroid carcinoma in pregnancy. A case report. J Reprod Med. 1987 Feb; 32(2):123-5.
    View in: PubMed
    Score: 0.010
  111. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study. Gynecol Oncol. 2006 Dec; 103(3):853-8.
    View in: PubMed
    Score: 0.009
  112. A community-driven action plan to eliminate breast and cervical cancer disparity: successes and limitations. J Cancer Educ. 2006; 21(1 Suppl):S91-100.
    View in: PubMed
    Score: 0.009
  113. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. J Clin Oncol. 2005 Nov 20; 23(33):8289-95.
    View in: PubMed
    Score: 0.009
  114. Influence of allogeneic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix. Gynecol Obstet Invest. 2003; 56(1):28-34.
    View in: PubMed
    Score: 0.008
  115. A comparison of four screening methods for cervical neoplasia in a developing country. Am J Obstet Gynecol. 2003 Feb; 188(2):395-400.
    View in: PubMed
    Score: 0.007
  116. Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer. Br J Cancer. 2002 Jan 07; 86(1):151-7.
    View in: PubMed
    Score: 0.007
  117. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Gynecol Oncol. 2001 Jun; 81(3):424-32.
    View in: PubMed
    Score: 0.007
  118. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells. Clin Cancer Res. 2001 Mar; 7(3 Suppl):804s-810s.
    View in: PubMed
    Score: 0.007
  119. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes. J Virol. 2000 May; 74(10):4729-37.
    View in: PubMed
    Score: 0.006
  120. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer. J Virol. 1999 Jul; 73(7):5402-10.
    View in: PubMed
    Score: 0.006
  121. Cyclin D1 overexpression and p53 mutation status in epithelial ovarian cancer. J Soc Gynecol Investig. 1999 Mar-Apr; 6(2):102-8.
    View in: PubMed
    Score: 0.006
  122. The National Cancer Data Base report on endometrial carcinoma in African-American women. Cancer. 1998 12 15; 83(12):2629-37.
    View in: PubMed
    Score: 0.006
  123. Cytoskeletal reorganization induced by retinoic acid treatment of human endometrial adenocarcinoma (RL95-2) cells is correlated with alterations in protein kinase C-alpha. Pathobiology. 1998; 66(6):284-92.
    View in: PubMed
    Score: 0.005
  124. Adeno-associated virus Rep78 inhibits oncogenic transformation of primary human keratinocytes by a human papillomavirus type 16-ras chimeric. Gynecol Oncol. 1997 Sep; 66(3):487-94.
    View in: PubMed
    Score: 0.005
  125. Expression of the farnesyltransferase beta-subunit gene in human ovarian carcinoma: correlation to K-ras mutation. Gynecol Oncol. 1997 Aug; 66(2):308-12.
    View in: PubMed
    Score: 0.005
  126. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res. 1997 Jul 15; 57(14):2884-7.
    View in: PubMed
    Score: 0.005
  127. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma. J Soc Gynecol Investig. 1997 Mar-Apr; 4(2):95-102.
    View in: PubMed
    Score: 0.005
  128. Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet Gynecol. 1995 May; 85(5 Pt 1):709-15.
    View in: PubMed
    Score: 0.004
  129. Screening for endometrial cancer. J Natl Med Assoc. 1994 Aug; 86(8):577-9.
    View in: PubMed
    Score: 0.004
  130. Ureteral strictures and fistulae following radical hysterectomy. Gynecol Oncol. 1984 Sep; 19(1):17-23.
    View in: PubMed
    Score: 0.002
  131. The effect of a full bladder on labor. Obstet Gynecol. 1983 Sep; 62(3):319-23.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.